2018 Drug Trials Snapshots Summary Report Released
This week, the U.S. Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) released a report titled "2018 Drug Trials Snapshots Summary Report." The report summarizes CDER's 2018 Drug Trials Snapshot program, highlighting the 59 novel drug approvals of 2018, by illustrating the demographic groups represented in the clinical trials for these novel drugs. In 2018, 43,966 patients participated in clinical trials for the 59 approved novel drugs. The summary provides an overall average of demographic groups followed by a more detailed summary table of the percent representation of sex, race, ethnicity and age groups participating in the clinical trials used to approve each novel drug. Similar summary reports of Drug Trials Snapshots were released by CDER in 2017 and 2018. Read more.
No hay comentarios:
Publicar un comentario